Anastasiia Kotaieva Sells 55,604 Shares of Nukkleus (NASDAQ:NUKK) Stock

Nukkleus Inc. (NASDAQ:NUKK) insider Anastasiia Kotaieva sold 55,604 shares of the business’s stock in a transaction dated Wednesday, December 24th. The shares were sold at an average price of $4.49, for a total transaction of $249,661.96. Following the completion of the transaction, the insider owned 1,205,593 shares in the company, valued at approximately $5,413,112.57. This trade represents a 4.41% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website.

Anastasiia Kotaieva also recently made the following trade(s):

• On Monday, December 29th, Anastasiia Kotaieva sold 75,000 shares of Nukkleus stock. The stock was sold at an average price of $4.09, for a total transaction of $306,750.00.
• On Friday, December 26th, Anastasiia Kotaieva sold 55,604 shares of Nukkleus stock. The shares were sold at an average price of $4.26, for a total transaction of $236,873.04.
• On Tuesday, December 23rd, Anastasiia Kotaieva sold 70,000 shares of Nukkleus stock. The stock was sold at an average price of $4.57, for a total value of $319,900.00.
• On Monday, December 22nd, Anastasiia Kotaieva sold 30,000 shares of Nukkleus stock. The stock was sold at an average price of $4.41, for a total value of $132,300.00.
• On Friday, December 19th, Anastasiia Kotaieva sold 70,000 shares of Nukkleus stock. The shares were sold at an average price of $4.53, for a total value of $317,100.00.
• On Thursday, December 18th, Anastasiia Kotaieva sold 38,744 shares of Nukkleus stock. The shares were sold at an average price of $4.72, for a total value of $182,871.68.

Nukkleus Stock Performance

Nukkleus stock opened at $4.03 on Friday. The business’s fifty day moving average is $5.53 and its two-hundred day moving average is $6.75. The firm has a market cap of $67.10 million, a P/E ratio of 0.25 and a beta of -6.66. Nukkleus Inc. has a 52 week low of $3.31 and a 52 week high of $40.98.

Hedge Funds Weigh In On Nukkleus

Several hedge funds have recently added to or reduced their stakes in NUKK. BNP Paribas Financial Markets acquired a new stake in Nukkleus in the second quarter worth about $56,000. Ausdal Financial Partners Inc. bought a new position in shares of Nukkleus in the 3rd quarter valued at about $105,000. Finally, UBS Group AG grew its position in shares of Nukkleus by 23.3% during the 3rd quarter. UBS Group AG now owns 80,512 shares of the company’s stock worth $564,000 after buying an additional 15,223 shares during the period. Institutional investors own 12.47% of the company’s stock.

Key Headlines Impacting Nukkleus

Here are the key news stories impacting Nukkleus this week:

• Positive Sentiment: Nukkleus completed the acquisition of Israeli defense-software firm Tiltan, adding ~30 years of defense AI expertise and established vendor relationships (IAI, Elbit, Rafael). This expands Nukkleus’s product set and creates a pathway to defense-market revenue. Nukkleus Completes Tiltan Acquisition
• Neutral Sentiment: Major outlets (MSN, TipRanks) circulated the acquisition news, increasing visibility; however, the announcements lack financial detail (purchase price, projected revenue, integration plan), so near‑term earnings impact is uncertain. TipRanks Announcement
• Negative Sentiment: Insider selling: director/officer Anastasiia Kotaieva sold several large blocks across Dec. 18–29 totaling roughly 286,208 shares for about $1.25M in proceeds (sales at ~$4.09–$4.72). Concentrated insider disposals can create selling pressure and be interpreted negatively by investors. SEC Filing (Insider Sales)

Analysts Set New Price Targets

NUKK has been the subject of several research reports. Wall Street Zen upgraded shares of Nukkleus from a “sell” rating to a “hold” rating in a research report on Sunday, November 23rd. Weiss Ratings reissued a “sell (d+)” rating on shares of Nukkleus in a research note on Wednesday, December 24th. One investment analyst has rated the stock with a Sell rating, According to MarketBeat, the company presently has a consensus rating of “Sell”.

Nukkleus Company Profile

Nukkleus Inc, a financial technology company, provides blockchain-enabled technology solutions worldwide. It focuses on providing software and technology solutions for retail foreign exchange trading industry. The company provides transactions platform for dealing and risk management services. It also offers cross-border payment and transactions solutions and blockchain-enabled financial services solutions to institutional investors. In addition, the company provides software, technology, customer sales and marketing, and risk management technology hardware and software solutions.